200 Participants Needed

Telehealth Hospice Visits for Breast Cancer

CS
Overseen ByClaire Smith, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Dana-Farber Cancer Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Research Team

CS

Claire Smith, MD

Principal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

The COMPASSION Study is for individuals with breast cancer who are currently receiving in-home hospice care. It's designed to understand the experience of patients, caregivers, and healthcare providers by using telehealth check-ins.

Inclusion Criteria

I can speak and agree to take a survey in 4-6 weeks if I'm well enough.
Hospice setting is within Massachusetts
I need an interpreter for my appointments, which will be arranged.
See 4 more

Exclusion Criteria

Hospice setting outside of Massachusetts
I started in home hospice care and may move to inpatient hospice.
I cannot give verbal consent.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (phone call)

Introduction and Consent

Introduction to study and survey by brief, verbal consent via phone call

1 week
1 visit (phone call)

Survey and Check-ins

Participants complete a survey and have 4 weekly check-ins via Zoom or phone call with the study team

4-6 weeks
4 visits (virtual)

Follow-up

Participants are monitored for completion of telehealth intervention

4 weeks

Treatment Details

Interventions

  • Telehealth Hospice Visits
Trial Overview This study tests the effectiveness of telehealth visits as a way to support people with breast cancer and their caregivers during in-home hospice care, involving regular virtual interactions with oncology teams.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Compassion CohortExperimental Treatment1 Intervention
25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone. * 4 weekly check-ins via Zoom or phone call with study team.
Group II: Usual Care CohortActive Control1 Intervention
25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dana-Farber Cancer Institute

Lead Sponsor

Trials
1,128
Recruited
382,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security